本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Talis Biomedical Corporation

2.84
0.0000
成交量:- -
成交額:- -
市值:517.68萬
市盈率:-0.10
高:2.84
開:2.84
低:2.84
收:2.84
52周最高:2.84
52周最低:1.04
股本:182.28萬
流通股本:91.42萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-28.0189
每股收益(LYR):-34.1165
淨資產收益率:-70.48%
總資產收益率:-29.59%
市淨率:0.11
市盈率(LYR):-0.08

資料載入中...

2024/10/10

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/20

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/09/17

重要事件披露

Form 8-K - Current report
2024/09/09

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/09/09

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/09/09

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/09/09

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/09/06

重要事件披露

Form 8-K - Current report
2024/09/06

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/19

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/01

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/03

重要事件披露

Form 8-K - Current report
2024/04/11

重要事件披露

Form 8-K - Current report